Latest / Lexcura Clinical Insights
GLP-1s: Benefits, Dangers, and the Litigation | Episode 73
GLP-1 medications have changed the treatment of type 2 diabetes and obesity, and semaglutide has been shown to reduce heart attack and stroke risk in high-risk patients. These powerful drugs also carry real risks. They include severe gastrointestinal effects, gastroparesis, ileus, pancreatitis, gallbladder disease, and aspiration during anesthesia. There is also a growing concern about sudden vision loss from a condition called NAION.
In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, looks at GLP-1s from both the clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.